Comparing CellCept vs Everolimus
| CellCept (mycophenolate mofetil) | Everolimus |
|
|---|
| CellCept (mycophenolate mofetil) | Everolimus |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Tuberous Sclerosis Complex, Breast Cancer, Renal Angiomyolipoma, Subependymal Giant Cell Astrocytoma, Brain Tumor, Organ Transplant - Rejection Prophylaxis... View more |
Related suggestions Organ Transplant, Rejection Prophylaxis
|
|||||||||||||||
| More about CellCept (mycophenolate mofetil) | More about Everolimus | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
CellCept has an average rating of 8.3 out of 10 from a total of 35 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 6% reported a negative effect. |
Everolimus has an average rating of 5.6 out of 10 from a total of 29 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 38% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all CellCept side effects |
View all Everolimus side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all CellCept prices |
View all Everolimus prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other mycophenolate mofetil brands include: Myhibbin | Afinitor, Afinitor Disperz, Torpenz, Zortress | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
18 hours |
35 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 352 drugs are known to interact with CellCept:
|
A total of 558 drugs are known to interact with Everolimus:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 03, 1995 |
March 30, 2009 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.